Want to see AU:OSL full AI Analyst Report?
OncoSil Medical Ltd (OSL) Income Statement
OncoSil Medical Ltd Income Statement
Last quarter (Q4 2026), OncoSil Medical Ltd's total revenue was $902.08K, an increase of 110.43% from the same quarter last year. In Q4, OncoSil Medical Ltd's net income was $-6.34M. See OncoSil Medical Ltd’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| $ 1.68M | $ 1.17M | $ 516.63K | $ 367.68K | $ 231.79K | |
| $ -6.20M | $ -1.08M | $ -993.00K | $ -1.22M | $ -6.73M | |
| $ 8.22M | $ 14.41M | $ 12.04M | $ 6.06M | $ 10.67M | |
| Depreciation and Amortization | $ 59.54K | $ 35.74K | $ 44.00K | $ 175.89K | $ 126.91K |
| $ -14.36M | $ -15.06M | $ -11.94M | $ -11.17M | $ -11.41M | |
| $ -14.42M | $ -15.49M | $ -13.03M | $ -12.55M | $ -11.41M | |
| $ 153.08K | $ 388.99K | $ 70.58K | $ 110.85K | $ -148.98K | |
| $ -14.26M | $ -15.10M | $ -12.96M | $ -12.44M | $ -11.56M | |
| $ -10.86M | $ -15.10M | $ -11.91M | $ -11.34M | $ -10.73M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.48 | $ -1.38 | $ -0.01 | $ -0.01 | $ -0.01 |
| Diluted EPS | $ -0.48 | $ -1.38 | $ -0.01 | $ -0.01 | $ -0.01 |
| Weighted Average Shares Outstanding | 22.65M | 10.93M | 2.22B | 1.20B | 1.06B |
| Weighted Average Shares Outstanding (Diluted) | 22.65M | 10.93M | 2.22B | 1.20B | 1.06B |
Currency in AUD